NTRS
72
-3
DAL
59
4
CRM
52
7
EXR
51
-2
PX
52
4
COST
53
-3
VMC
59
3
PNW
59
4
DD
44
4
PM
77
-2
AMZN
56
4
AES
40
2
SCHW
62
4
CFG
68
2
LB
32
4
ORLY
47
-3
LNC
49
6
XYL
47
2
AN
54
2
PPG
40
3
NTRS
72
-3
DAL
59
4
CRM
52
7
EXR
51
-2
PX
52
4
COST
53
-3
VMC
59
3
PNW
59
4
DD
44
4
PM
77
-2
AMZN
56
4
AES
40
2
SCHW
62
4
CFG
68
2
LB
32
4
ORLY
47
-3
LNC
49
6
XYL
47
2
AN
54
2
PPG
40
3
Financhill
Back

Verizon Communications Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
47

VZ
Verizon Communications

Last Price:
$42.12
Seasonality Move:
-0.01%
Sell
37

APLS
Apellis Pharmaceuticals

Last Price:
$18.39
Seasonality Move:
-9.52%
Sell
47
Verizon Communications (VZ) is a Sell

Is Verizon Communications a Buy, Sell or Hold?

  • The current Verizon Communications [VZ] share price is $42.63. The Score for VZ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.61. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VZ Stock Price Chart

What is Verizon Communications's stock price today?

  • The Verizon Communications share price today is $42.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.61
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

VZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 46.04 Sell
Chaikin Money Flow: 9491586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.5 - 44) Sell
Bollinger Bands (100): (41.57 - 44.39) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 51.96 Buy
Chaikin Money Flow: 1572607 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.38 - 19.08) Buy
Bollinger Bands (100): (17.59 - 26.19) Sell

VZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.36 Buy
20-day SMA: 43.13 Sell
50-day SMA: 43.31 Sell
200-day SMA: 42.48 Buy
8-day EMA: 42.47 Buy
20-day EMA: 42.9 Sell
50-day EMA: 43.13 Sell
200-day EMA: 42.29 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.23 Buy
20-day SMA: 18.35 Buy
50-day SMA: 18.22 Buy
200-day SMA: 26.62 Sell
8-day EMA: 18.22 Buy
20-day EMA: 18.32 Buy
50-day EMA: 19.15 Sell
200-day EMA: 26.8 Sell

Verizon Communications Earnings Growth & VZ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.03 per share, an increase this year of $0.09 per share, and an increase next year of $0.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Verizon Communications Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):